Article Categories
Allergy and Immunology
Cardiology
Clinical Procedures
Critical Care
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genomic Medicine
Hematology
Infectious Diseases
Nephrology
Neurology
Obstetrics and Gynecology
Oncology
Pathology
Perioperative Care
Physical & Rehabilitation
Psychiatry
Pulmonology
Radiology
Rheumatology
Sports Medicine
Browse Categories
Browse Drugs
Browse Journals
Search
Browse Categories
Browse Categories
Allergy and Immunology
Cardiology
Clinical Procedures
Critical Care
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genomic Medicine
Hematology
Infectious Diseases
Nephrology
Neurology
Obstetrics and Gynecology
Oncology
Pathology
Perioperative Care
Physical & Rehabilitation
Psychiatry
Pulmonology
Radiology
Rheumatology
Sports Medicine
Browse Journals
Publications by authors named "Inka Vallbracht Vallbracht"
Page
1
of
1
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al' by Benucci .
Hendrik Schulze-Koops
Klaus Krueger
Inka Vallbracht Vallbracht
Rebecca Hasseli
Alla Skapenko
Ann Rheum Dis
August 2022
View Article and Find Full Text PDF
Privacy Policy
Site Map
Contact Us
© LitMetric 2025. All rights reserved.
